HomeIDRSF • OTCMKTS
add
Idorsia Ltd
Previous close
$1.31
Year range
$0.70 - $2.88
Market cap
213.14M CHF
Avg Volume
137.00
P/E ratio
-
Dividend yield
-
Primary exchange
SWX
Market news
The Motley Fool
11 hours ago
The Nasdaq Sell-Off Has Made These 3 Great Growth Stocks Even Better Buys
0.95%
Financials
Income Statement
Revenue
Net income
| (CHF) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 59.90M | 178.42% |
Operating expense | 66.34M | -15.12% |
Net income | -84.00M | 28.00% |
Net profit margin | -140.24 | 74.14% |
Earnings per share | — | — |
EBITDA | -54.85M | 51.13% |
Effective tax rate | 0.16% | — |
Balance Sheet
Total assets
Total liabilities
| (CHF) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 124.36M | -21.20% |
Total assets | 505.90M | 1.18% |
Total liabilities | 1.72B | 16.98% |
Total equity | -1.21B | — |
Shares outstanding | 188.74M | — |
Price to book | -0.20 | — |
Return on assets | -28.98% | — |
Return on capital | -166.38% | — |
Cash Flow
Net change in cash
| (CHF) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -84.00M | 28.00% |
Cash from operations | -11.00M | 90.09% |
Cash from investing | -736.00K | -101.41% |
Cash from financing | 26.19M | — |
Net change in cash | -38.68M | -3,988.37% |
Free cash flow | 30.57M | 133.47% |
About
Idorsia is a Swiss pharmaceutical research company in Allschwil, near Basel, Switzerland. Wikipedia
Founded
2017
Website
Employees
938
